Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3276 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-20

Study Completion Date

2023-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will investigate the epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of cerebral venous thrombosis in China.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Retrospective Cohort Study of Intracerebral Hemorrhage

NCT04803292

Intracerebral Hemorrhage

UNKNOWN

Cerebral Venous Thrombosis Cohort Study in China Mainland

NCT03919305

Cerebral Venous Sinus Thrombosis Deep Cerebral Vein Thrombosis Cortical Vein Thrombosis

NOT_YET_RECRUITING

Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma

NCT04500795

Chronic Subdural Hematoma Subdural Hematoma

WITHDRAWN NA

Prospective Cohort Study of Intracerebral Hemorrhage

NCT04707105

Intracerebral Hemorrhage

RECRUITING

Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage

NCT05502874

Intracerebral Hemorrhage Neurologic Deficits Hemorrhagic Stroke +1 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The epidemiology, risk factors, diagnosis and treatment of Cerebral Venous Thrombosis (CVT) in China are still unclear. A retrospective hospital-based study will be conducted at fifty different hospitals across 31 provinces in China. This study will use ICD-10 to search patients diagnosed with CVT between January 1, 2018 and June 15, 2022 across 31 provinces and municipalities of 104 hospitals in China. Risk factors, clinical and radiological findings, treatment and short-term outcomes will be recorded from the hospital record system. Finally, a prospective follow-up will be conducted for all of the patients enrolled above. By combining data collected from retrospective hospital records with the new follow-up, it will be possible to better understand the epidemiology, risk factors, diagnosis, treatment and the long-term prognosis of CVT in China.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Vein Thrombosis Cerebral Venous Sinus Thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein thrombosis diagnosed by digital subtraction angiography (DSA), magnetic resonance venography (MRV), computed tomography venography (CTV) or high-resolution magnetic resonance imaging (HR-MRI).